Sponsor Oversight- Part 2
Part two of this post provides two case studies from inspections where critical and major findings have been identified in regards to Organisation’s Oversight of Clinical Trials of IMP.
National and International GCP Symposia
Posted by:
Paula Walker, Posted on:
-
Categories:
Compliance matters, Events and symposia, Good clinical practice
On the 5 and 6 September, the GCP Inspectorate held their symposium and were joined by colleagues from the FDA, the Brazilian authority ANVISA and the Israeli Ministry of Health.
Related content and links
Recent Comments